Demonstrated the rapid technical transfer of a client process to Concept Life Sciences GMP facilities to enable the manufacture of 1.5Kg of API to support early phase clinical trials.
Complex eight step synthesis involving novel chemistry, harsh/hazardous reaction conditions and a technically challenging final API crystallisation.
